Pacific Biosciences of California Inc. sell StockNews.com
Start price
13.01.24
/
50%
€5.85
Target price
13.01.25
-
Performance (%)
-69.97%
Price
25.07.24
€1.76
Summary
This prediction is currently active. Massive losses of -69.97% have been the result for the SELL prediction by StockNews_com. This prediction currently runs until 13.01.25. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Pacific Biosciences of California Inc. | 10.325% | 10.325% |
iShares Core DAX® | 0.039% | 0.567% |
iShares Nasdaq 100 | -4.018% | -5.554% |
iShares Nikkei 225® | -2.389% | -1.434% |
iShares S&P 500 | -2.115% | -2.351% |
Comments by StockNews_com for this prediction
In the thread Pacific Biosciences of California Inc. diskutieren
Pacific Biosciences of California, Inc. (NASDAQ: PACB) was upgraded by analysts at StockNews.com to a "sell" rating.
Ratings data for PACB provided by MarketBeat
Stopped prediction by StockNews_com for Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc.
Start price
Target price
Perf. (%)
€1.39
18.04.24
18.04.24
-
18.04.25
18.04.25
26.39%
25.07.24
25.07.24
Pacific Biosciences of California Inc.
Start price
Target price
Perf. (%)
€3.86
12.03.24
12.03.24
-
12.03.25
12.03.25
-54.52%
25.07.24
25.07.24
Pacific Biosciences of California Inc.
Start price
Target price
Perf. (%)
€9.37
29.12.23
29.12.23
-
29.12.24
29.12.24
-81.24%
25.07.24
25.07.24